Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Issue 2 , Pages 193-205 , June 2006

Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome

  • Ricardo Azziz, MD, MBA, MPH (Chair and Professor of Obstetrics and Gynecology and Medicine)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1 310 423 7433; fax: +1 310 423 3470.

References 

  1. Stein IF, Leventhal NL. Amenorrhea associated with bilateral polycystic ovaries. American Journal of Obstetrics and Gynecology. 1935;29:181–191
  2. Azziz R, Woods KS, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. The Journal of Clinical Endocrinology and Metabolism. 2004;89:2745–2749
  3. Hull MG. Ovulation failure and induction. Clinical Obstetrics and Gynaecology. 1981;8:753–785
  4. Legro RS. The genetics of obesity. Lessons for polycystic ovary syndrome. Annals of the New York Academy of Sciences. 2000;900:193–202
  5. Azziz R. Androgen excess is the key element in the polycystic ovary syndrome. Fertility and Sterility. 2003;80:252–254
  6. Legro RS, Kunselman AR, Dunaif A. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. The American Journal of Medicine. 2001;111:607–613
  7. Carmina E, Legro RS, Stamets K, et al. Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet. Human Reproduction. 2003;18:2289–2293
  8. Azziz R, Sanchez LA, Knochenhauer ES, et al. Androgen excess in women: experience with over 1000 consecutive patients. The Journal of Clinical Endocrinology and Metabolism. 2004;89:453–462
  9. Hahn S, Tan S, Elsenbruch S, et al. Clinical and biochemical characterization of women with polycystic ovary syndrome in north Rhine-Westphalia. Hormone and Metabolic Research. 2005;37:438–444
  10. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989;38:1165–1174
  11. Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. The Journal of Clinical Endocrinology and Metabolism. 1999;84:165–169
  12. Carmina E, Lobo RA. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Fertility and Sterility. 2004;82:661–665
  13. DeUgarte CM, Bartolucci AA, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertility and Sterility. 2005;83:1454–1460
  14. Goodarzi MO, Korenman SG. The importance of insulin resistance in polycystic ovary syndrome. Fertility and Sterility. 2003;80:255–258
  15. Rebar R, Judd HL, Yen SSC, et al. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. Journal of Clinical Investigation. 1976;57:1320–1329
  16. Conway GS, Honour JW, Jacobs HS. Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clinical Endocrinology (Oxford). 1989;30:459–470
  17. Anttila L, Ding Y-Q, Ruutiainen K, et al. Clinical features and circulating gonadotropin, insulin, and androgen interactions in women with polycystic ovarian disease. Fertility and Sterility. 1991;55:1057–1061
  18. van Santbrink EJ, Hop WC, Fauser BC. Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome. Fertility and Sterility. 1997;67:452–458
  19. Arroyo A, Laughlin GA, Morales AJ, Yen SS. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity. The Journal of Clinical Endocrinology and Metabolism. 1997;82:3728–3733
  20. Taylor AE, McCourt B, Martin KA, et al. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism. 1997;82:2248–2256
  21. Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In:  Dunaif A,  Givens JR,  Haseltine FP,  Merriam GR editor. Polycystic Ovary Syndrome. Boston: Blackwell Scientific Publications; 1992;p. 377–384
  22. Homburg R. What is polycystic ovarian syndrome? A proposal for a consensus on the definition and diagnosis of polycystic ovarian syndrome. Human Reproduction. 2002;17:2495–2499
  23. The rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility. 2004;81:19–25
  24. The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction. 2004;19:41–47
  25. Azziz R. Diagnostic criteria for polycystic ovary syndrome: a reappraisal. Fertility and Sterility. 2005;83:1343–1346
  26. Carmina E, Lobo RA. Polycystic ovaries in hirsute women with normal menses. The American Journal of Medicine. 2001;111:602–606
  27. Eden JA, Place J, Carter GD, et al. Is the polycystic ovary a cause of infertility in the ovulatory woman?. Clinical Endocrinology (Oxford). 1989;30:77–82
  28. Kousta E, White DM, Cela E, et al. The prevalence of polycystic ovaries in women with infertility. Human Reproduction. 1999;14:2720–2723
  29. Knochenhauer ES, Key TJ, Kahsar-Miller M, et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. The Journal of Clinical Endocrinology and Metabolism. 1998;83:3078–3082
  30. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. The Journal of Clinical Endocrinology and Metabolism. 1999;84:4006–4011
  31. Asuncion M, Calvo RM, San Millan JL, et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected caucasian women from Spain. The Journal of Clinical Endocrinology and Metabolism. 2000;85:2434–2438
  32. Michelmore KF, Balen AH, Dunger DB, Vessey MP. Polycystic ovaries and associated clinical and biochemical features in young women. Clinical Endocrinology (Oxford). 1999;51:779–786
  33. US census bureau. Census 2000 Summary File 1, QT-P3. http://factfinder.census.gov/servlet/DatasetMainPageServlet?_program=DEC&_lang=en
  34. Hartz AJ, Barboriak PN, Wong A, et al. The association of obesity with infertility and related menstrual abnormalities in women. International Journal of Obesity. 1979;3:57–73
  35. Heinonen S, Korhonen S, Hippelainen M, et al. Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study. American Journal of Obstetrics and Gynecology. 2001;184:289–296
  36. Escobar-Morreale HF, Roldan B, Barrio R, et al. High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus. The Journal of Clinical Endocrinology and Metabolism. 2000;85:4182–4187
  37. Conn JJ, Jacobs HS, Conway GS. The prevalence of polycystic ovaries in women with type 2 diabetes mellitus. Clinical Endocrinology (Oxford). 2000;52:81–86
  38. Peppard HR, Marfori J, Iuorno MJ, Nestler JE. Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes. Diabetes Care. 2001;24:1050–1052
  39. Allen SE, Potter HD, Azziz R. Prevalence of hyperandrogenemia among nonhirsute oligo-ovulatory women. Fertility and Sterility. 1997;67:569–572
  40. Goodarzi MO, Quiñones MJ, Azziz R, et al. Polycystic ovary syndrome in Mexican–Americans: prevalence and association with the severity of insulin resistance. Fertility and Sterility. 2005;84:766–769
  41. King RA, Rotter JI, Motulsky AG. The Genetic Basis of Common Diseases. 2nd edn. New York: Oxford University Press; 2002;
  42. Legro RS, Strauss JF. Molecular progress in infertility: polycystic ovary syndrome. Fertility and Sterility. 2002;78:569–576
  43. Kahsar-Miller MD, Nixon C, Boots LR, et al. Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertility and Sterility. 2001;75:53–58
  44. Legro RS, Driscoll D, Strauss JF, et al. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proceedings of the National Academy of Sciences of the USA. 1998;95:14956–14960
  45. Legro RS, Kunselman AR, Demers L, et al. Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism. 2002;87:2134–2138
  46. Legro RS, Bentley-Lewis R, Driscoll D, et al. Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity. The Journal of Clinical Endocrinology and Metabolism. 2002;87:2128–2133
  47. Norman RJ, Masters S, Hague W. Hyperinsulinemia is common in family members of women with polycystic ovary syndrome. Fertility and Sterility. 1996;66:942–947
  48. Yildiz BO, Yarali H, Oguz H, Bayraktar M. Glucose intolerance, insulin resistance, and hyperandrogenemia in first-degree relatives of women with polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism. 2003;88:2031–2036
  49. Kaushal R, Parchure N, Bano G, et al. Insulin resistance and endothelial dysfunction in the brothers of Indian subcontinent Asian women with polycystic ovaries. Clinical Endocrinology (Oxford). 2004;60:322–328
  50. Colilla S, Cox NJ, Ehrmann DA. Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first-degree relatives. The Journal of Clinical Endocrinology and Metabolism. 2001;86:2027–2031
  51. Ehrmann DA, Sturis J, Byrne MM, et al. Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. Journal of Clinical Investigation. 1995;96:520–527
  52. Nelson VL, Legro RS, Strauss JF, McAllister JM. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Molecular Endocrinology. 1999;13:946–957
  53. Dunaif A, Wu X, Lee A, Diamanti-Kandarakis E. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). American Journal of Physiology Endocrinology and Metabolism. 2001;281:E392–E399
  54. Rosenbaum D, Haber RS, Dunaif A. Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes. American Journal of Physiology. 1993;264:E197–E202
  55. Ciaraldi TP, el-Roeiy A, Madar Z, et al. Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. The Journal of Clinical Endocrinology and Metabolism. 1992;75:577–583
  56. Escobar-Morreale HF, Luque-Ramirez M, San Millan JL. The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocrine Reviews. 2005;26:251–282
  57. Parikh H, Groop L. Candidate genes for type 2 diabetes. Reviews in Endocrine and Metabolic Disorders. 2004;5:151–176

PII: S1521-690X(06)00022-4

doi: 10.1016/j.beem.2006.02.005

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Issue 2 , Pages 193-205 , June 2006

Article Tools